Drug intelligence / Profile preview

pdhx plasmid vaccine

Development stage
Preclinical
Lead developer
University of Washington
Modality
Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intradermal
01

Overview

The pdhx plasmid vaccine is a preclinical DNA plasmid vaccine encoding pyruvate dehydrogenase complex component X (PDHX), an early-stage breast cancer antigen. Developed by researchers at the University of Washington, the vaccine is designed for the prevention and treatment of breast cancer. PDHX is overexpressed during the early stages of breast tumorigenesis and is essential for breast cancer cell survival. Immunization with the pdhx plasmid vaccine stimulates antigen-specific CD4+ and CD8+ T-cell immune responses, leading to type I T-cell-mediated tumor growth inhibition and prevention of spontaneous tumorigenesis in breast cancer models.

Other names
Pdhx DNA vaccinePdhx vaccinepyruvate dehydrogenase complex component X plasmid vaccine
02

Targets

PDH (Pyruvate dehydrogenase complex)TLR9 (Toll-like receptor 9)

Beyond the preview

Go deeper on pdhx plasmid vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pdhx plasmid vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call